Literature DB >> 15916563

The burden of atopic dermatitis: impact on the patient, family, and society.

Christie L Carroll1, Rajesh Balkrishnan, Steven R Feldman, Alan B Fleischer, Janeen C Manuel.   

Abstract

Atopic dermatitis is a common disease of increasing prevalence. Affected individuals must cope with a significant psychosocial burden, in addition to dealing with the medical aspects of the disease. Furthermore, because this is primarily a disease of childhood, family members, especially parents, are also affected by the condition. Individuals and family members are burdened with time-consuming treatment regimens for the disease, as well as dietary and household changes. The financial impact of atopic dermatitis on families can also be great. Moreover, the cost to society is significant, with estimates ranging from less than 100 dollars to more than 2000 dollars per patient per year. It is estimated that the direct cost of atopic dermatitis in the United States alone is almost 1 billion dollars per year. Reducing the onus of this disease must take into account the full breadth of its burden. Targeting parents and caregivers with education and psychosocial support can decrease family and personal burden, which in turn may decrease the cost of treating the condition because of better medical, psychosocial, and family outcomes.

Entities:  

Mesh:

Year:  2005        PMID: 15916563     DOI: 10.1111/j.1525-1470.2005.22303.x

Source DB:  PubMed          Journal:  Pediatr Dermatol        ISSN: 0736-8046            Impact factor:   1.588


  86 in total

1.  Cost-effectiveness model for a specific mixture of prebiotics in The Netherlands.

Authors:  I Lenoir-Wijnkoop; W M C van Aalderen; G Boehm; D Klaassen; A B Sprikkelman; M J C Nuijten
Journal:  Eur J Health Econ       Date:  2010-12-17

2.  Environmental tobacco smoke and the risk of eczema symptoms among school children in South Africa: a cross-sectional study.

Authors:  Joyce Shirinde; Janine Wichmann; Kuku Voyi
Journal:  BMJ Open       Date:  2015-08-26       Impact factor: 2.692

3.  Predicting eczema severity beyond childhood.

Authors:  Kam Lun Hon; Yin-Ching K Tsang; Terence Chuen W Poon; Nga Hin Pong; Matthew Kwan; Shirley Lau; Yuen-Chun Chiu; Hin-Hei Wong; Ting-Fan Leung
Journal:  World J Pediatr       Date:  2015-12-18       Impact factor: 2.764

Review 4.  The role of the skin microbiome in atopic dermatitis.

Authors:  Michael R Williams; Richard L Gallo
Journal:  Curr Allergy Asthma Rep       Date:  2015-11       Impact factor: 4.806

5.  [Decreased professional performance and quality of life in patients with moderate-to-severe atopic eczema : Results from the German atopic eczema registry TREATgermany].

Authors:  E Haufe; S Abraham; A Heratizadeh; I Harder; A Zink; E Weisshaar; A Kleinheinz; R von Kiedrowski; M Worm; M Bell; A Wollenberg; K Neubert; P Staubach-Renz; M Hilgers; T Bieber; I Fell; B Homey; I Effendy; M Mempel; K Schäkel; S Beissert; S Weidinger; T Werfel; J Schmitt
Journal:  Hautarzt       Date:  2018-10       Impact factor: 0.751

6.  Eczema prevalence in the United States: data from the 2003 National Survey of Children's Health.

Authors:  Tatyana E Shaw; Gabriel P Currie; Caroline W Koudelka; Eric L Simpson
Journal:  J Invest Dermatol       Date:  2010-08-26       Impact factor: 8.551

7.  Quality of life and disease severity are correlated in patients with atopic dermatitis.

Authors:  Dong Ha Kim; Kapsok Li; Seong Jun Seo; Sun Jin Jo; Hyeon Woo Yim; Churl Min Kim; Kyu Han Kim; Do Won Kim; Moon-Bum Kim; Jin Woo Kim; Young Suck Ro; Young Lip Park; Chun Wook Park; Seung-Chul Lee; Sang Hyun Cho
Journal:  J Korean Med Sci       Date:  2012-10-30       Impact factor: 2.153

Review 8.  Efficacy of health education on treatment of children with atopic dermatitis: a meta-analysis of randomized controlled trials.

Authors:  Yunling Li; Ting Han; Wei Li; Yin Li; Xiaoxuan Guo; Lei Zheng
Journal:  Arch Dermatol Res       Date:  2020-04-15       Impact factor: 3.017

9.  Mental health comorbidity in patients with atopic dermatitis.

Authors:  Pouya Yaghmaie; Caroline W Koudelka; Eric L Simpson
Journal:  J Allergy Clin Immunol       Date:  2012-12-13       Impact factor: 10.793

Review 10.  Topical pimecrolimus: a review of its use in the management of pediatric atopic dermatitis.

Authors:  Lily P H Yang; Monique P Curran
Journal:  Paediatr Drugs       Date:  2009       Impact factor: 3.022

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.